These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11829712)

  • 21. The new macrolide antibiotics. Azithromycin and clarithromycin.
    Stein GE; Havlichek DH
    Postgrad Med; 1992 Jul; 92(1):269-72, 277-82. PubMed ID: 1319579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azithromycin: the first azalide antibiotic.
    Ballow CH; Amsden GW
    Ann Pharmacother; 1992 Oct; 26(10):1253-61. PubMed ID: 1330097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse effects of macrolide antibacterials.
    Periti P; Mazzei T; Mini E; Novelli A
    Drug Saf; 1993 Nov; 9(5):346-64. PubMed ID: 8280403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrolides: structures and microbial targets.
    Retsema J; Fu W
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S3-10. PubMed ID: 11574188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study.
    Malhotra-Kumar S; Lammens C; Coenen S; Van Herck K; Goossens H
    Lancet; 2007 Feb; 369(9560):482-90. PubMed ID: 17292768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telithromycin: new preparation. A needless addition to the other macrolides.
    Prescrire Int; 2003 Feb; 12(63):8-11. PubMed ID: 12602373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute bacterial skin infections in pediatric medicine: current issues in presentation and treatment.
    Hedrick J
    Paediatr Drugs; 2003; 5 Suppl 1():35-46. PubMed ID: 14632104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy.
    Kirst HA; Sides GD
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1419-22. PubMed ID: 2684005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial therapy for chronic bacterial prostatitis.
    Perletti G; Marras E; Wagenlehner FM; Magri V
    Cochrane Database Syst Rev; 2013 Aug; (8):CD009071. PubMed ID: 23934982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrolide and ketolide resistance with Streptococcus pneumoniae.
    Doern GV
    Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline.
    Zuckerman JM; Qamar F; Bono BR
    Infect Dis Clin North Am; 2009 Dec; 23(4):997-1026, ix-x. PubMed ID: 19909895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New macrolides].
    Portier H; Buisson M; Chavanet P
    Rev Prat; 1994 Jun; 44(12):1629-34. PubMed ID: 7939238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The newer macrolides. Azithromycin and clarithromycin.
    Zuckerman JM; Kaye KM
    Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumococcal macrolide resistance--myth or reality?
    Amsden GW
    J Antimicrob Chemother; 1999 Jul; 44(1):1-6. PubMed ID: 10459803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
    Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
    J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical use of the new macrolides, azalides, and streptogramins in pediatrics.
    Adam D
    J Chemother; 1992 Dec; 4(6):371-5. PubMed ID: 1337554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrolides in cystic fibrosis.
    Bell SC; Senini SL; McCormack JG
    Chron Respir Dis; 2005; 2(2):85-98. PubMed ID: 16279156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro activity of dirithromycin in comparison with other new and established macrolides.
    Bauernfeind A
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():39-49. PubMed ID: 8478311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH; Friedel HA; McTavish D
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Macrolides, a group of antibiotics with a broad spectrum of activity].
    Hof H
    Immun Infekt; 1994 Apr; 22(2):66-71. PubMed ID: 7959864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.